Eli Lilly says it plans to apply for U.S. Food and Drug Administration (FDA) approval by the end of the year to market the ...

Some would say Eli Lilly just had its Novo Nordisk moment. Analysts mostly agree that the selloff in Lilly shares after the ...

Donald Trump announces major change to "frivolous grants" Trump’s tariffs are now in place. Alcohol, a cup of joe and Toyotas are about to cost a whole lot more Workers Reveal What You Should ...

Eli Lilly is one step closer to bringing an oral weight loss medicine to the booming obesity drug market. A clinical trial saw people lose 12% of body weight.

In May, it announced it would acquire SiteOne Therapeutics, a drugmaker with a promising investigational medicine for pain.

This followed the release of its earnings performance that saw the company swing to a net income of $11 million from a $50 ...

The stock is struggling badly, and if things don't improve in short order, Eli Lilly will be on track for its worst ...